Bayer Healthcare realigns diagnostics division

Published: 26-Apr-2004

The diagnostics division of Bayer HealthCare is to be divided into two entities with effect from 1 June: Bayer HealthCare Diagnostics Self-Testing Systems Division (STS) and Bayer HealthCare Diagnostics Professional Testing Systems Division (PTS).


The diagnostics division of Bayer HealthCare is to be divided into two entities with effect from 1 June: Bayer HealthCare Diagnostics Self-Testing Systems Division (STS) and Bayer HealthCare Diagnostics Professional Testing Systems Division (PTS).

The decision is intended to accelerate the company's concentration on consumer health, and to afford both units greater operational flexibility in their respective markets. 'This change will allow us to better address the very different business conditions that exist in different parts of the diagnostics market,' said Rolf Classon, head of Bayer HealthCare.

The newly created STS division markets blood glucose monitoring systems directly to users, and will add an important dimension to Bayer HealthCare's overall portfolio of consumer products portfolio. It is based in Elkhart, Indiana, and will be headed by Joe Martin.

Based in Tarrytown, New York and headed by Dr Hans Hiller, the PTS division will concentrate its focus on hospitals, large-scale laboratories and physician's offices to solidify and increase its market share.

Wolfgang Hartwig, head of the current diagnostics division, will take over as global head of pharmaceutical research and development in Wuppertal, Germany. He will also be chairman of Bayer HealthCare's research and development committee.

According to Bayer HealthCare, the appointment of Hartwig further underlines the importance of pharma and its current r&d pipeline. 'To continue to build value in our pharmaceuticals business, our top priority has to be the expansion and continual improvement of our pipeline. It is critical to our future success,' said Classon.

  

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now